Heron Therapeutics, Inc. · NASDAQ:HRTX

Rubric Capital Management LP reported a 17.50% stake in Heron Therapeutics, Inc. (Schedule 13D/A)

Event Aug 8, 2025 · Filed Aug 12, 2025

Rubric Capital Management LP reported a 17.50% stake in Heron Therapeutics, Inc., 29,100,728 shares, with active intent on Aug 8, 2025. Filed Aug 12, 2025 (Schedule 13D/A).

Stake
17.50%
Shares
29,100,728
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Rubric Capital Management LP17.50%29,100,728
David Rosen17.50%29,100,728

Source

View original at SEC

Related